Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

NCT04301843 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
131
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Giselle Sholler

Collaborators